S2Medical Information

S2Medical AB (publ) is a Swedish biomedtech group advancing wound healing and combating antibiotic-resistant bacteria. From our laboratories in Linköping, we developed EPIPROTECT®, a biosynthetic dressing trusted in burn and wound care internationally, manufactured in Sweden and distributed globally by ABENA through EPIPROTECT AB. Today, our pipeline is spearheaded by Admercin™, an antimicrobial peptide platform engineered to target resistant pathogens. Together with our commercial portfolio of clinical instruments and odour-neutralising products, we bridge the gap between scientific breakthrough and standard of care. S2Medical is headquartered in Sweden with an office in Dubai, and is listed on Nasdaq First North Growth Market Stockholm under the ticker S2M.